उत्पाद विवरण
Azashine 100 mg Injection is a targeted anticancer therapy specifically designed for the treatment of myelodysplastic syndrome (MDS), a condition characterized by the ineffective production of blood cells in the bone marrow. As a member of the demethylation agents class, Azashine works by blocking the process of DNA methylation, which is often linked to abnormal gene activity and the subsequent production of defective cells. This mechanism not only helps in restoring normal gene expression but also promotes the development of healthy blood cells while effectively eliminating malignant cells within the bone marrow. It is essential to monitor for potential side effects and discuss any pre-existing health conditions with your healthcare provider before starting treatment. Azashine's role in correcting the blood cell production process makes it a vital option for patients suffering from MDS. Always follow your healthcare professional's guidance on dosage and administration for optimal results. With its precise action, Azashine 100 mg Injection plays a crucial role in managing the complexities of myelodysplastic syndrome, supporting patients on their journey toward recovery.Hospital-Focused Antibiotic SolutionAzashine 100 mg Injection is tailored for hospital settings where precision and sterility are paramount. As a broad-spectrum beta-lactam antibiotic, it targets a wide range of bacterial infections effectively. The product's sterile powder form ensures stability and efficacy until reconstitution, making it a trusted choice for healthcare professionals requiring reliable infection management in critical care environments.
Easy Storage and Long Shelf LifeDesigned for bulk hospital supply, Azashine comes with a generous shelf life of 24 months. The glass vial packaging protects the integrity of the medication, allowing for extended storage without compromising efficacy. With each box containing 60 vials, it is a practical option for large-scale healthcare facilities and distributors seeking efficient supply chain solutions.
FAQ's of Azashine 100 mg Injection:
Q: How should Azashine 100 mg Injection be reconstituted and administered?
A: Azashine 100 mg Injection must be reconstituted with a suitable sterile solvent by qualified healthcare professionals. After preparation, it should be administered intravenously (IV) or intramuscularly (IM) as directed by a doctor.
Q: What is the recommended usage area for Azashine 100 mg Injection?
A: This medication is recommended exclusively for hospital use and should be handled only by licensed medical personnel in a controlled clinical environment.
Q: When is Azashine 100 mg Injection typically used?
A: Azashine is prescribed for the treatment of serious bacterial infections when a beta-lactam antibiotic is indicated. Administration is determined by a physician based on patient needs.
Q: Where is Azashine 100 mg manufactured and supplied from?
A: This product is manufactured in India and is distributed, exported, and supplied by reputable wholesalers, distributors, and traders across various regions.
Q: What benefits does Azashine 100 mg Injection offer for hospital supply?
A: Azashine ensures rapid, reliable management of bacterial infections in hospitals. Its sterile powder formulation extends shelf life and allows for flexible storage and use.
Q: Is a prescription required to purchase Azashine 100 mg Injection?
A: Yes, Azashine 100 mg Injection is a prescription-only medicine and can only be administered under the supervision of a registered medical doctor.
Q: What is included in one box of Azashine 100 mg Injection?
A: Each box contains 60 glass vials of sterile powder, suitable for hospital inventory and bulk procurement.
Send Email 
जांच भेजें
जांच भेजें
एसएमएस भेजें
मुझे निःशुल्क कॉल करें
English
Spanish
French
German
Italian
Chinese (Simplified)
Japanese
Korean
Arabic
Portuguese